Systematic review of factors affecting the ratios of morphine and its major metabolites

被引:121
作者
Faura, CC
Collins, SL
Moore, RA
McQuay, HJ
机构
[1] Univ Miguel Hernandez, Inst Neurociencias, Dept Farmacol, Alicante 03080, Spain
[2] Univ Oxford, Oxford Radcliffe Hosp, Pain Res & Nuffield Dept Anaesthet, Oxford OX3 7LJ, England
关键词
systematic review; morphine; morphine-3-glucuronide; morphine-6-glucuronide;
D O I
10.1016/S0304-3959(97)00142-5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
In a systematic review of 57 studies with information on 1232 patients we examined the effect of age, renal impairment, route of administration, and method of analysis on the ratios of morphine-3-glucuronide:morphine (M3G:M) and morphine-6-glucuronide:morphine (M6G:M) and the relative concentrations of M3G and M6G. Across all studies the range of the ratios of metabolites to morphine was wide (0.001-504 for M3G:M, and 0-97 for M6G:M). Neonates produced morphine glucuronides at a lower rate than older children or adults. Metabolite ratios were higher in renal impairment. Routes of administration which avoided first pass metabolism (intravenous, transdermal, rectal, intramuscular, epidural and intrathecal) resulted in lower metabolite production than oral, buccal or sublingual. Metabolite production was similar for single and multiple dosing. There was no evidence of differences between methods of assay. There was a high correlation between the two glucuronide metabolites in spite of the different situations studied, supporting a single glucuronidating enzyme. Morphine was present in CSF at a fourfold higher concentration than the glucuronide metabolites. (C) 1998 International Association for the Study of Pain. Published by Elsevier Science B.V.
引用
收藏
页码:43 / 53
页数:11
相关论文
共 53 条
[1]  
AHERNE GW, 1985, LANCET, V2, P210
[2]  
BALL M, 1985, LANCET, V1, P784
[3]   MORPHINE-6-GLUCURONIDE MIGHT MEDIATE THE PROLONGED OPIOID EFFECT OF MORPHINE IN ACUTE-RENAL-FAILURE [J].
BODD, E ;
JACOBSEN, D ;
LUND, E ;
RIPEL, A ;
MORLAND, J ;
WIIKLARSEN, E .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1990, 9 (05) :317-321
[4]   PARADOXICAL PAIN [J].
BOWSHER, D .
BRITISH MEDICAL JOURNAL, 1993, 306 (6876) :473-474
[5]   MORPHINE PHARMACOKINETICS IN RENAL-FAILURE [J].
CHAUVIN, M ;
SANDOUK, P ;
SCHERRMANN, JM ;
FARINOTTI, R ;
STRUMZA, P ;
DUVALDESTIN, P .
ANESTHESIOLOGY, 1987, 66 (03) :327-331
[6]   MORPHINE-6-GLUCURONIDE HAS HIGH-AFFINITY FOR THE OPIOID RECEPTOR [J].
CHRISTENSEN, CB ;
JORGENSEN, LN .
PHARMACOLOGY & TOXICOLOGY, 1987, 60 (01) :75-76
[7]  
Coffman BL, 1997, DRUG METAB DISPOS, V25, P1
[8]   THE ENANTIOSELECTIVE GLUCURONIDATION OF MORPHINE IN RATS AND HUMANS - EVIDENCE FOR THE INVOLVEMENT OF MORE THAN ONE UDP-GLUCURONOSYLTRANSFERASE ISOENZYME [J].
COUGHTRIE, MWH ;
ASK, B ;
RANE, A ;
BURCHELL, B ;
HUME, R .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (19) :3273-3280
[9]  
ELLISON NM, 1984, CLIN PHARMACY, V3, P614
[10]   Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain [J].
Faura, CC ;
Moore, RA ;
Horga, JF ;
Hand, CW ;
McQuay, HJ .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1996, 11 (02) :95-102